Delivery Order SPE2DB20D1100-SPE2DB25FD5Z2
- Not listed
- This is a $2,183.59 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CRYSELLE-28 TABLET 28S, a medical product, with a period of performance through April 15, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,089.41 Firm Fixed Price Delivery Order is for the supply of CRYSELLE-28 TABLET 28S, a pharmaceutical product. The contract has a period of performance through May 6, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,556.30 firm fixed-price contract is for the supply of CRYSELLE-28 TABLET 28S, a pharmaceutical product, with a performance period ending on May 16, 2025. The contract is not set aside and was awarded on May 15, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $375,250 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4561401252, described as CRYSELLE-28 TABLET 28S. Performance will take place in Conshohocken, Pennsylvania under a schedule contract vehicle from July 3 to July 5, 2023. As a leading provider of medical supplies to the Department of Defense, Amerisourcebergen will deliver the specified medication to the customer agency. No subcontractors or set aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $1,887.09, is a firm fixed price delivery order for the supply of CRYSELLE-28 TABLET 28S, a pharmaceutical product. The award is associated with a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CRYSELLE-28 TABLET 28S, a pharmaceutical product, with a ceiling value of $1,867.56 and a performance period ending on June 17, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $308.16 to Amerisourcebergen Drug Corporation. The order is for 4561563150 CRYSELLE-28 TABLET 28S to be delivered to a location in Conshohocken, Pennsylvania by July 24, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform under the contract from its Conshohocken facility. The Defense Logistics Agency utilizes such contracts and delivery orders to...
- The Defense Logistics Agency awarded a $1,173.45 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562355585 CRYSELLE-28 TABLET 28S. The delivery order is under an indefinite-delivery/indefinite-quantity contract vehicle to provide pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania from September 29, 2023 through October 2, 2023. As the prime contractor, Amerisourcebergen will be...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,153.66, is for the delivery of CRYSELLE-28 TABLET 28S, a pharmaceutical product, with a performance period through March 31, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred fifty-four thousand eight dollars to Amerisourcebergen Drug Corporation for pharmaceutical item 4561636272, described as CRYSELLE-28 TABLET 28S. The order was placed under an existing Prime Vendor contract vehicle and will be fulfilled by Amerisourcebergen from its facility in Conshohocken, Pennsylvania by July 31, 2023 to support DLA missions. No subcontractors or set aside designations were identified....
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD5Z2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,846.41 to AmerisourceBergen Drug Corp for Cryselle-28 tablets on July 23, 2025, with completion targeted for July 24, 2025. This firm fixed-price delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Cryselle-28 is an oral contraceptive medication used for family planning and reproductive health support within the military and federal healthcare systems. This delivery order falls under AmerisourceBergen Drug Corp's comprehensive pharmaceutical supply relationship with the Defense Logistics Agency, which includes a $1 billion indefinite delivery contract (SPE2DX) through DLA Troop Support Medical running through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen maintains a substantial portfolio of competitively awarded contracts supplying brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs globally. The contract reflects the company's established capability to deliver critical pharmaceutical commodities to the Defense Health Agency and other federal healthcare systems through flexible contract vehicles designed to meet ongoing military medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/23/25 |